BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 5, 2026
Home » Authors » Lynn Yoffee

Lynn Yoffee

lynn.yoffee@clarivate.com
Articles

ARTICLES

iScience's microcatheters get FDA nod for glaucoma therapy

Sep. 2, 2008
By Lynn Yoffee

Biotronik EchoCRT study gets under way with first implant

Aug. 29, 2008
By Lynn Yoffee
Millions of people with heart failure could ultimately benefit from life-saving cardiac resynchronization therapy (CRT) if a new trial just underway proves that it helps. (Medical Device Daily)
Read More

Osteoarthritis trial begins with 'electroceutical' device

Aug. 26, 2008
By Lynn Yoffee

Psychiatric alliance to address treatment-resistant depression

Aug. 22, 2008
By Lynn Yoffee

Cangen, Dai Nippon developing test for early lung disease

Aug. 21, 2008
By Lynn Yoffee
Early stage lung cancer often is caught by accident via an imaging test for another problem. Screening for lung cancer, typically via chest X-rays or sputum tests, has been unreliable and isn't recommended even for high-risk patients. (Diagnostics & Imaging Week)
Read More

Cangen, Dai Nippon developing test for early lung disease

Aug. 15, 2008
By Lynn Yoffee
Early stage lung cancer often is caught by accident via an imaging test for another problem. Screening for lung cancer, typically via chest X-rays or sputum tests, has been unreliable and isn't recommended even for high-risk patients. (Medical Device Daily)
Read More

UCLA research team develops saliva test for oral cancer

Aug. 14, 2008
By Lynn Yoffee

UCLA research team develops saliva test for oral cancer

Aug. 12, 2008
By Lynn Yoffee
Most of the substances found in blood can also be detected and analyzed from saliva. But biomarkers in saliva are at much lower concentrations, challenging researchers to develop more sensitive biosensors for a variety of diagnostics. (Medical Device Daily)
Read More

Nano-Nose sniffs out diseases unlike e-nose predecessors

Aug. 11, 2008
By Lynn Yoffee
Electronic noses are familiar tools across a wide variety of industries with applications ranging from security to environmental oversight. But like their canine counterparts, special training is involved both for the handler and sensor, they can sometimes be awkward to use. And though often large in size, they may be sable to detect only one thing. (Medical Device Daily)
Read More

Financings roundup: Sierra raises 'A' $21.5M to pump up its CNS drug delivery method

Aug. 1, 2008
By Lynn Yoffee
View All Articles by Lynn Yoffee

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 4, 2026.
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Concept art for headache

    Slate Medicines launches with focus on headache disorders

    BioWorld Science
    Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing